Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment.
Moshe C OrnsteinLisa C RosenblattXin YinViviana Del TejoSarah B GuttenplanFlavia EjzykowiczKathleen BeusterienOliver WilldeMauri S MackieGrace SkilesMarc DeCongelioPublished in: Patient preference and adherence (2024)
In this study, patients highlighted that improving survival time was the most important and that QoL is also an important consideration. Discussions during treatment decision-making may benefit from broader conversations around treatment characteristics, including impacts on QoL and convenience of the regimen.